Regulation of RNA Polymerase I Stability and Function

Area of Science:

• Molecular Biology
• Biochemistry
• Cancer Therapeutics

Background:

• RNA polymerase I (Pol I) is crucial for synthesizing ribosomal RNA (rRNA), a process vital for ribosome biogenesis and cell proliferation.
• Pol I exhibits high processivity, rapid initiation, and elongation rates, enabling efficient rRNA production.
• Cancer cells hijack Pol I transcription control to sustain high proliferation rates.

Purpose of the Study:

• To review the current understanding of RNA polymerase I transcription regulation.
• To discuss chemical biology approaches for developing targeted Pol I inhibitors.
• To highlight challenges and successes in creating specific Pol I-targeting agents.

Main Methods:

• Literature review of research on Pol I transcription regulation.
• Analysis of chemical biology efforts and drug development strategies targeting Pol I.
• Evaluation of agent specificity and selectivity in preclinical and clinical studies.

Main Results:

• Pol I transcription is tightly regulated, but cancer cells aberrantly activate it.
• Targeting Pol I offers a potential therapeutic vulnerability for cancer treatment.
• Development of targeted agents faces challenges due to promiscuous mechanisms but shows promise with specific compounds.

Conclusions:

• Dysregulated Pol I transcription is a hallmark of cancer, presenting a viable therapeutic target.
• Chemical biology is advancing the development of specific inhibitors against Pol I.
• Future efforts should focus on agents with high specificity and selectivity for effective cancer therapy.